Cargando…
Development of Novel Therapeutics for Schizophrenia Treatment Based on a Selective Positive Allosteric Modulation of α1-Containing GABAARs—In Silico Approach
For the development of atypical antipsychotics, the selective positive allosteric modulation of the ionotropic GABAA receptor (GABAAR) has emerged as a promising approach. In the presented research, two unrelated methods were used for the development of QSAR models for selective positive allosteric...
Autores principales: | Đorđević, Vladimir, Petković, Milan, Živković, Jelena, Nikolić, Goran M., Veselinović, Aleksandar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406691/ https://www.ncbi.nlm.nih.gov/pubmed/36005130 http://dx.doi.org/10.3390/cimb44080234 |
Ejemplares similares
-
Downregulation of GABAARα1 Aggravates Comorbidity of Epilepsy and Migraine via the TLR4 Signaling Pathway
por: Lin, Yao, et al.
Publicado: (2022) -
Interactions between GHRH and GABAARs in the brains of patients with epilepsy and in animal models of epilepsy
por: Tang, Shirong, et al.
Publicado: (2017) -
KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia
por: Gao, Yuan, et al.
Publicado: (2022) -
Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia
por: Djordjević, Vladimir V., et al.
Publicado: (2022) -
Role of GABAAR in the Transition From Acute to Chronic Pain and the Analgesic Effect of Electroacupuncture on Hyperalgesic Priming Model Rats
por: Wang, Sisi, et al.
Publicado: (2021)